My research interests have evolved around the exploration of cellular pathophysiological mechanisms contributing to disease initiation and progression, which could subsequently support the development of novel diagnostic and/or therapeutic molecular markers. Within this context, I investigated the underlying molecular pathogenic mechanisms of tubal ectopic pregnancy in relation to sexually transmitted infections and the expression of novel implantation markers during my PhD studies. The outcomes were disseminated in well-reputable journals in the fields of reproductive biology and medicine. Following being appointed as Assistant Professor in Umm Al-Qura University in 2011, I also succeeded in obtaining three research grants that were based on the published results. Since many of the cellular mechanisms involved in embryo implantation and trophoblast invasion are adapted by malignant cells during cancer progression, I have later developed major interest in studying the molecular oncogenic and anti-tumorigenic pathways. My research aims to develop novel diagnostic/prognostic and therapeutic molecular markers with special emphasis on colon cancer. Furthermore, my research focuses on re-discovering the potential therapeutic efficacy of already approved drugs for the treatment of chronic diseases (e.g. metformin, vitamin D, calcium channel blockers, etc.) alongside other nutraceuticals (e.g. thymoquinone, bitter water melon, etc.) as promising therapeutics and/or chemopreventive agents against colon cancer. During my current employment, I have obtained 10 research grants with a total of 12.3 million Saudi Riyals (equivalent to 3.3 million USD), subdivided into 5.25 million SAR as PI and the remaining as a CO-I.  I have over 45 published studies and reviews as either first author or a co-author, among which 42 are indexed in PubMed. I also attended and presented the results in national and international conferences and I contributed chapters in books. I have also gained excellent experience in designing research studies. I have excellent knowledge and experience about several molecular techniques including ELISA, real-time PCR, immunohistochemistry, immunofluorescence, laser capture microscopy, digital image analysis, Western Blot and gene sequencing. I am also ambitious to learn new research techniques, including multiplex ELISA, confocal microscopy, flow cytometry and constructing and analysing tissue arrays. My future research aims to develop new diagnostic/prognostic markers in a variety of human cancers through clinical, experimental animal and in vitro cancer models with special interest in colon cancer.